期刊文献+

核医学检查受检者所受辐射剂量分析 被引量:12

Analysis of patient radiation dose from nuclear medicine examinations
原文传递
导出
摘要 目的 对核医学检查受检者所受辐射剂量进行测量和分析,以有效剂量表征受检者受到的辐射强度.方法 对核医学检查受检者进行分类,并测量计算所受放射性药物的辐射剂量,受检者所受计算机断层扫描(CT)辐射剂量,通过CT扫描参数和受检者信息等计算得到,上述两者相加换算得到受检者检查所受的有效剂量,并分析受检者所受辐射剂量的影响因素.结果 受检者正电子发射断层计算机成像(PET-CT)检查受到正电子放射性药物18F-氟代脱氧葡萄糖(18F-FDG)、18F-氟代胸苷(18 F-FLT)、11C-胆碱(11 C-choline)、11 C-蛋氨酸(12C-MET)和11C-乙酸盐(11 C-Ac)辐射所致有效剂量分别为(5.06±0.73)、(4.74±1.29)、(1.71 ±0.05)、(3.18 ±0.69)和(1.08±0.19)mSv;CT常规扫描辐射有效剂量为(8.80 ±0.58) mSv,若增加诊断CT扫描,接受的有效剂量可增大至27 mSv;单光子发射计算机断层成像(ECT)检查受到单光子放射性药物99Tcm-亚甲基二磷酸盐(99Tcm-MDP)、99 Tcm-大颗粒聚合白蛋白(99 Tcm-MAA)、99Tcm-二乙基三胺五乙酸(99Tcm-DTPA)、99Tcm-甲氧基异丁基异腈(99Tcm-MIBI)和99Tcm-焦磷酸盐(99Tcm-PYP)辐照所致的有效剂量分别为(4.63±0.01)、(1.71±0.01)、(1.18±0.01)、(7.19±0.03)和(4.18 ±0.01)mSv.结论 核医学检查受检者受到放射性药物辐射的有效剂量在1.08~7.19 mSv之间,PET-CT检查中CT所致有效剂量是8.80 mSv. Objective To measure and analyze the radiation dose for patients undergoing nuclear medicine examination,and to characterize radiation exposure of patients by using the estimated effective dose.Methods Patients undergoing nuclear medicine examinations were classified and the radiation doses from radiopharmaceuticals to patients were measured and calculated.Meanwhile,radiation exposure from computed tomography (CT) procedure was calculated on the basis of CT protocols and patients' information.The effective doses to patient from both the radiopharmaceutical and CT scan radiation were calculated and the factors influencing patient radiation doses were analyzed.Results For the patients undergoing positron emission tomography-computed tomography (PET-CT) examination,the average effective doses from positron radiopharmaceutical 18F-fluorodeoxyglucose (18F-FDG),18F-fluoro-l-thymidine (18 F-FLT),11C-choline,11 C-methylmethionine (11 C-MET) and 11 C-acetate (11 C-Ac) were (5.06 ± 0.73),(4.74±1.29),(1.71 ±0.05),(3.18±0.69) and (1.08±0.19) mSv,respectively.CTscan caused average effective dose was (8.80 ± 0.58) mSv.If a full diagnostic CT investigation was performed,the effective dose might be up to 27 mSv.Whereas for emission computed tomography (ECT) examinations,the average effective dose to the patients irradiated by single photon radiopharmaceutical 99Tcm-methylenediphosphonate (99Tcm-MDP),99Tcm-macroaggregated albumin (99Tcm-MAA),99Tcm-diethylentriaminpentaacetic acid (99 Tcm-DTPA),99Tcm-methoxyisobutyl isonitrile (99 Tcm-MIBI) and 99Tcm-pyrophosphate (99Tcm-PYP) were (4.63 ± 0.01),(1.71 ± 0.01),(1.18 ± 0.01),(7.19 ± 0.03) and (4.18 ± 0.01) mSv,respectively.Conclusions Radiopharmaceutical irradiation caused effective dose to the patients undergoing nuclear medicine examinations is from 1.08 to 7.19 mSv,while CT scan cause average effective dose is 8.80 mSv in PET-CT examination.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2015年第9期705-708,共4页 Chinese Journal of Radiological Medicine and Protection
基金 国家自然科学基金(81371592,81172083) 北京市自然科学基金(7132040)
关键词 PET—CT ECT 辐射 吸收剂量 核医学 PET-CT ECT Radiation Absorbed dose Nuclear medicine
  • 相关文献

参考文献12

  • 1Smolarz K, Krause BJ, Graner FP, et al. Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour- specific probe for PET/CT imaging: BAY 85-$050 [ J]. Eur J Nucl Med Mol Imaging, 2013, 40(12) :1861-1868.
  • 2王风,杨志,张岩,赵伟,李囡,谢卿,林新峰,朱华,陈菩芸,范洋.^18F-氟代脱氧葡萄糖PET/CT检查患者所受辐射剂量的测量分析[J].中华放射医学与防护杂志,2013,33(6):662-663. 被引量:11
  • 3Snyder WS, Ford MR, Warner GG, et al. MIRD pamphlet No 11 : "S" absorbed dose per unit cumulated activity for selected radionuclides and organs [ R ]. New York: Society of Nuclear Medicine, 1975.
  • 4Hays MT, Watson EE, Thomas SR, et al. MIRD dose estimate report No 19: radiation absorbed dose estimates from SF-FDG [R]. J NuclMed, 2002, 43(2): 210-214.
  • 5International Commission on Radiological Protection. ICRP Publication 53. Radiation dose to patients tom radiopharmaceuticals[R]. Oxford: Pergamon Press, 1988.
  • 6International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals ( addendum 2 to ICRP publication 53) [R] Oxford: Pergamon Press, 1998.
  • 7International Commission on Radiologieal Protection. ICRP Publication 106. Addendum 3 to ICRP publication 53. Radiation dose to patients from radiopharmaceuticals [ R ]. Oxford: Pergamon Press, 2008.
  • 8European Commission. European guidelines on quality criteria computed tomography. Report EUR 16262 EN[ R]. Luxembourg : EC, 2000 : 1-107.
  • 9International Commission on Radiological Protection. ICRP publication 103. The 2007 recommendations of the International Commission on Radiological Protection [ R ]. Oxford: Pergamon Press, 2007.
  • 10International Commission on Radiological Protection. Radiation and your patient: a guide for medical practitioners[ R]. Oxtbrd: Pergamon Press, 2001.

二级参考文献10

  • 1International Commission on Radiological Protection. Radiationdose to patients from radiopharmaceuticals. ICRP Publication 53.Oxford; Pergamon Press, 1988.
  • 2International Commission on Radiological Protection. Radiationdose to patients from radiopharmaceuticals. Addendum 3 to ICRPpublication 53. ICRP Publication 106. Oxford; Pergamon Press,2008.
  • 3Snyder WS, Ford MR, Warner GG, et al. “S,” absorbed doseper unit cumulated activity for selected radionuclides and organs,nm/mird pamphlet No. 11. New York: Society of NuclearMedicine, 1975.
  • 4Hays MT, Watson EE, Thomas SR, et al. MIRD dose estimatereport No. 19 : radiation absorbed dose estimates from 18F-FDG.J Nucl Med, 2002,43(2) :210-214.
  • 5European Commission. Report EUR 16262. European guidelineson quality criteria for computed tomography, 2010.
  • 6International Commission on Radiological Protection. ICRPPublication 102. Managing patient dose in multi-detectorcomputed tomography (MDCT). Oxford: Pergamon Press, 2007.
  • 7International Commission on Radiological Protection. ICRPPublication 103. The 2007 Recommendations of the InternationalCommission on Radiological Protection. Oxford : Pergamon Press,2007.
  • 8Willowson KP,Bailey EA, Bailey DL. A retrospective evaluationof radiation dose associated with low dose FDG protocols in whole-body PET/CT. Australas Phys Eng Sci Med, 2012,35 ( 1 ):49-53.
  • 9Leide-Svegbom S. Radiation exposure of patients and personnelfrom a PET/CT procedure with 18F-FDG. Radi.at Prot Dosim,2010’ 139(1-3) : 208-213.
  • 10Brix G,Lechel U, Glatting G, et al. Radiation exposure ofpatients undergoing whole-body dual-modality 18 F-FDG PET/CTexaminations. J Nucl Med, 2005,46(4) :608-613.

共引文献10

同被引文献91

引证文献12

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部